About Xycrobe Therapeutics
Xycrobe Therapeutics is a company based in San Diego (United States) founded in 2014 was acquired by Crown Laboratories in May 2019.. Xycrobe Therapeutics has raised $200 thousand across 1 funding round from investors including Crown Laboratories. Xycrobe Therapeutics offers products and services including Aesthetics Products, Consumer Skincare, Prescription Products, Docuseries, and Microbiome Facility Services. Xycrobe Therapeutics operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Xycrobe Therapeutics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$200 K (USD)
in 1 rounds
-
Latest Funding Round
$200 K (USD), Seed
Jan 16, 2015
- Investors
-
Employee Count
Employee Count
-
Acquired by
Crown Laboratories
(May 22, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xycrobe Therapeutics
Xycrobe Therapeutics offers a comprehensive portfolio of products and services, including Aesthetics Products, Consumer Skincare, Prescription Products, Docuseries, and Microbiome Facility Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Skincare solutions for aesthetic treatments and enhancements
Daily skincare items focused on microbiome health
Therapeutics for dermatological conditions
Educational content on skin microbiome science
Facilities for microbiome research and product development
Funding Insights of Xycrobe Therapeutics
Xycrobe Therapeutics has successfully raised a total of $200K through 1 strategic funding round. The most recent funding activity was a Seed round of $200 thousand completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $199,999
-
First Round
First Round
(16 Jan 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2015 | Amount | Seed - Xycrobe Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Xycrobe Therapeutics
Xycrobe Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Crown Laboratories. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
OTC, prescription, skin care, and oral care products are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Xycrobe Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Xycrobe Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Xycrobe Therapeutics Comparisons
Competitors of Xycrobe Therapeutics
Xycrobe Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Xycrobe Therapeutics
Frequently Asked Questions about Xycrobe Therapeutics
When was Xycrobe Therapeutics founded?
Xycrobe Therapeutics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Xycrobe Therapeutics located?
Xycrobe Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Xycrobe Therapeutics a funded company?
Xycrobe Therapeutics is a funded company, having raised a total of $200K across 1 funding round to date. The company's 1st funding round was a Seed of $200K, raised on Jan 16, 2015.
What does Xycrobe Therapeutics do?
Xycrobe Therapeutics was founded in 2014 in San Diego, United States. Microbiome-based therapies for dermatological diseases are developed through a platform of engineered, probiotic-like microbes. These microbes are designed to produce and secrete medicinal products in targeted ways. The technology addresses indications including anti-aging, axillary odor, foot odor, rosacea, alopecia, onychomycosis, wound healing, and additional areas within the biotech sector focused on skin conditions.
Who are the top competitors of Xycrobe Therapeutics?
Xycrobe Therapeutics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Xycrobe Therapeutics offer?
Xycrobe Therapeutics offers Aesthetics Products, Consumer Skincare, Prescription Products, Docuseries, and Microbiome Facility Services.
Who are Xycrobe Therapeutics's investors?
Xycrobe Therapeutics has 1 investor. Key investors include Crown Laboratories.